Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2
Clinical trial NCT00085839 · COMPLETED
Trial details
- NCT number
- NCT00085839
- Sponsor
- OSI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2007-03-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.